Targeting Feeding Arteries of Angiogenesis-Dependent Lesion Using Activin Receptor-Like Kinase 1 (ALK1) Regulatory Fragment

被引：0
|
作者：
Yonenaga, Yoshikuni [1 ]
Suzuki, Rumi [1 ]
Lan, Fei [1 ]
Seki, Tsugio [1 ]
机构：
[1] Med Coll Georgia, Augusta, GA 30912 USA
来源：
MOLECULAR THERAPY | 2009年 / 17卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：S248 / S248
页数：1
相关论文
共 50 条
  • [21] Activin receptor-like kinase 1 modulates transforming growth factor-β1 signaling in the regulation of angiogenesis
    Oh, SP
    Seki, T
    Goss, KA
    Imamura, T
    Yi, Y
    Donahoe, PK
    Li, L
    Miyazono, K
    ten Dijke, P
    Kim, S
    Li, E
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) : 2626 - 2631
  • [22] Accumulated Knowledge of Activin Receptor-Like Kinase 2 (ALK2)/Activin A Receptor, Type 1 (ACVR1) as a Target for Human Disorders
    Katagiri, Takenobu
    Tsukamoto, Sho
    Kuratani, Mai
    BIOMEDICINES, 2021, 9 (07)
  • [23] Implications of mutations of activin receptor-like kinase 1 gene (ALK1) in addition to bone morphogenetic protein receptor II gene (BMPR2) in children with pulmonary arterial hypertension
    Fujiwara, Maya
    Yagi, Hisato
    Matsuoka, Rumiko
    Akimoto, Kaoru
    Furutani, Michiko
    Imamura, Shin-Ichiro
    Uehara, Ritei
    Nakayama, Tomotaka
    Takao, Atsuyoshi
    Nakazawa, Makoto
    Saji, Tsutomu
    CIRCULATION JOURNAL, 2008, 72 (01) : 127 - 133
  • [24] Targeting Activin Receptor-Like Kinase 1 Inhibits Angiogenesis and Tumorigenesis through a Mechanism of Action Complementary to Anti-VEGF Therapies
    Hu-Lowe, Dana D.
    Chen, Enhong
    Zhang, Lianglin
    Watson, Katherine D.
    Mancuso, Patrizia
    Lappin, Patrick
    Wickman, Grant
    Chen, Jeffrey H.
    Wang, Jianying
    Jiang, Xin
    Amundson, Karin
    Simon, Ronald
    Erbersdobler, Andreas
    Bergqvist, Simon
    Feng, Zheng
    Swanson, Terri A.
    Simmons, Brett H.
    Lippincott, John
    Casperson, Gerald F.
    Levin, Wendy J.
    Stampino, Corrado Gallo
    Shalinsky, David R.
    Ferrara, Katherine W.
    Fiedler, Walter
    Bertolini, Francesco
    CANCER RESEARCH, 2011, 71 (04) : 1362 - 1373
  • [25] TCF7L2(Transcription Factor 7-Like 2) Regulates Activin Receptor-Like Kinase 1(ALK1)/Smad1 Pathway for Development of Diabetic Nephropathy
    Araoka, Toshikazu
    Abe, Hideharu
    Nagai, Kojiro
    Kishi, Fumi
    Tominaga, Tatsuya
    Yoshikawa, Kazuhiro
    Kishi, Seiji
    Murakami, Taichi
    Hirano, Takahiro
    Shigeta, Reiko
    Matsuura, Motokazu
    Mima, Akira
    Takahashi, Toshikazu
    Doi, Toshio
    DIABETES, 2009, 58 : A7 - A7
  • [26] Transcription Factor 7-Like 2 (TCF7L2) Regulates Activin Receptor-Like Kinase 1 (ALK1)/Smad1 Pathway for Development of Diabetic Nephropathy
    Araoka, Toshikazu
    Abe, Hideharu
    Tominaga, Tatsuya
    Mima, Akira
    Matsubara, Takeshi
    Murakami, Taichi
    Kishi, Seiji
    Nagai, Kojiro
    Doi, Toshio
    MOLECULES AND CELLS, 2010, 30 (03) : 209 - 218
  • [27] Immunohistochemical Analysis of Activin Receptor-Like Kinase 1 (ACVRL1/ALK1) Expression in the Rat and Human Hippocampus: Decline in CA3 During Progression of Alzheimer's Disease
    Adams, Stephanie L.
    Benayoun, Laurent
    Tilton, Kathy
    Mellott, Tiffany J.
    Seshadri, Sudha
    Blusztajn, Jan Krzysztof
    Delalle, Ivana
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 63 (04) : 1433 - 1443
  • [28] P7170, a novel inhibitor of mTORC1/mTORC2 and Activin receptor-like Kinase 1 (ALK1) inhibits the growth of non small cell lung cancer
    Venkatasubbaiah A Venkatesha
    Asavari Joshi
    Magesh Venkataraman
    Vinay Sonawane
    Dimple Bhatia
    Prashant Tannu
    Julie Bose
    Sarika Choudhari
    Ankita Srivastava
    Prashant Kumar Pandey
    Vaibhavi J Lad
    Ramachandra Sangana
    Tausif Ahmed
    Anagha Damre
    Vijaykumar Deore
    Bichismita Sahu
    Sanjay Kumar
    Somesh Sharma
    Veena R Agarwal
    Molecular Cancer, 13
  • [29] Activin Receptor-Like Kinase Receptors ALK5 and ALK1 Are Both Required for TGFβ-Induced Chondrogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells
    de Kroon, Laurie M. G.
    Narcisi, Roberto
    Davidson, Esmeralda N. Blaney
    Cleary, Mairead A.
    van Beuningen, Henk M.
    Koevoet, Wendy J. L. M.
    van Osch, Gerjo J. V. M.
    van der Kraan, Peter M.
    PLOS ONE, 2015, 10 (12):
  • [30] Activin Receptor-Like Kinase 1: a Novel Anti-angiogenesis Target from TGF-β Family
    Vecchia, Luca
    Olivieri, Carla
    Scotti, Claudia
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2013, 13 (10) : 1398 - 1406
12345